Arkadios Wealth Advisors »

Vaneck Vectors Pharmaceutical etf shares owned by Arkadios Wealth Advisors

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Arkadios Wealth Advisors from 13F filings

Historical chart of Arkadios Wealth Advisors investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Arkadios Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Arkadios Wealth Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $856k 8.3k 103.12
2025-09-30 $695k 7.7k 90.36
2025-06-30 $684k 7.8k 87.96

More positions owned by Arkadios Wealth Advisors

Apple Stock (AAPL)
Nvidia Corporation Stock (NVDA)
Spdr S&p 500 Etf Trust Etf (SPY)
Microsoft Corp Stock (MSFT)
Ishares Core S&p 500 Etf Etf (IVV)
Amazon Stock (AMZN)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Invesco Qqq Trust Series I Etf (QQQ)
Angel Oak Income Etf Etf (CARY)
Jpmorgan Chase & Co Stock (JPM)
Broadcom Stock (AVGO)
Fidelity Total Bond Etf Etf (FBND)
Ishares S&p 500 Growth Etf Etf (IVW)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Invesco Russell 1000 Dynamic Multifactor Etf Etf (OMFL)

View all positions for Arkadios Wealth Advisors

Top funds holding Vaneck Vectors Pharmaceutical etf

Healthcare Of Ontario Pension Plan Trust Fund
Goldman Sachs Group
British Columbia Investment Management Corporation
Wells Fargo & Company
Clal Insurance Enterprises Holdings
J.Safra Asset Management
Bnp Paribas Arbitrage, Snc
Avalon Trust
Jpmorgan Chase & Co
J. Goldman & Co
Miller Investment Management
Adamsbrown Wealth Consultants
Susquehanna International
UBS Group
LPL Financial

View all funds holding Vaneck Vectors Pharmaceutical etf